Silobreaker Logotype

360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Impax Laboratories Inc

Entity type image

Type: Company

Name: Impax Laboratories Inc

Nationality: United States

First reported May 17 2013 - Updated May 17 2013 - 2 reports

Thoratec Corporation

3 Healthcare Stocks Stories To Close Out the Trading Week

Impax Laboratories ( NASDAQ:IPXL ): Closing price $18.42On Friday, Impax said that its generics division, Global Pharmaceuticals, began shipment of authorized generic Zomig (zolmitriptan) tablets and orally disintegrating tablets, 2.5 mg and 5 mg, in ... [Published Wall St. Cheat Sheet - May 17 2013]

Entities: Zomig, Thoratec Corporation, Insulin

First reported May 17 2013 - Updated May 17 2013 - 4 reports

Impax Labs launches generic version of Zomig

HAYWARD, Calif. -- Impax Laboratories Inc. said Friday it is now selling a generic version of the migraine drug Zomig.Impax is now selling a low-cost generic version of Zomig tablets and orally disintegrating Zomig tablets in two strengths. Zomig, or ... [Published CNBC - May 17 2013]

Entities: Zomig, Impax Laboratories Inc, Generic Version

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Form 4 IMPAX LABORATORIES INC For: May 15 Filed by: FLEMING NIGEL

StreetInsider.com - Form 4 IMPAX LABORATORIES INC For: May 15 Filed by: FLEMING NIGEL ... [Published Street Insider - May 16 2013]

Entities: Impax Laboratories Inc

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Form 4 IMPAX LABORATORIES INC For: May 15 Filed by: CHAO ALLEN

StreetInsider.com - Form 4 IMPAX LABORATORIES INC For: May 15 Filed by: CHAO ALLEN ... [Published Street Insider - May 16 2013]

Entities: Impax Laboratories Inc

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Form 4 IMPAX LABORATORIES INC For: May 15 Filed by: MARKBREITER MICHAEL

StreetInsider.com - Form 4 IMPAX LABORATORIES INC For: May 15 Filed by: MARKBREITER MICHAEL ... [Published Street Insider - May 16 2013]

Entities: Impax Laboratories Inc

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Form 4 IMPAX LABORATORIES INC For: May 15 Filed by: BEN-MAIMON CAROLE

StreetInsider.com - Form 4 IMPAX LABORATORIES INC For: May 15 Filed by: BEN-MAIMON CAROLE ... [Published Street Insider - May 16 2013]

Entities: Impax Laboratories Inc

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Form 4 IMPAX LABORATORIES INC For: May 15 Filed by: BENET LESLIE Z

StreetInsider.com - Form 4 IMPAX LABORATORIES INC For: May 15 Filed by: BENET LESLIE Z ... [Published Street Insider - May 16 2013]

Entities: Impax Laboratories Inc

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Form 4 IMPAX LABORATORIES INC For: May 15 Filed by: BURR ROBERT L

StreetInsider.com - Form 4 IMPAX LABORATORIES INC For: May 15 Filed by: BURR ROBERT L ... [Published Street Insider - May 16 2013]

Entities: Impax Laboratories Inc

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Form 4 IMPAX LABORATORIES INC For: May 15 Filed by: Reasons Bryan M.

StreetInsider.com - Form 4 IMPAX LABORATORIES INC For: May 15 Filed by: Reasons Bryan M. ... [Published Street Insider - May 16 2013]

Entities: Impax Laboratories Inc

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Impax Laboratories Q1 net income increases

8 minutes ago, 9:47am (ET) 05/14/2013 DatamonitorImpax Laboratories, Inc., a specialty pharmaceutical company, has reported that net income for the first quarter ended March 31, 2013 was $105.44 million, or $1.55 per diluted share, compared to $12.36 ... [Published Zecco - May 14 2013]

Entities: Impax Laboratories Inc, Larry Hsu, Gross Profit Margin, Doctor of Philosophy

First reported May 13 2013 - Updated May 14 2013 - 2 reports

What Companies Will This FDA Decision Impact?

The U.S. Food and Drug Administration ruled Friday that a new version of Opana ER, a painkilling drug, does not deter drug abuse better than earlier versions. Companies will be allowed to make generic versions of the older Opana ER, reports The Wall ... [Published Wall St. Cheat Sheet - May 13 2013]

Entities: Opana ER, FDA Food & Drug Administration, anodyne, Actavis, Abuse

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Form 4 IMPAX LABORATORIES INC For: May 11 Filed by: NESTOR MICHAEL

StreetInsider.com - Form 4 IMPAX LABORATORIES INC For: May 11 Filed by: NESTOR MICHAEL ... [Published Street Insider - May 14 2013]

Entities: Impax Laboratories Inc

Quotes

More From BioPortfolio on "Impax Laboratories Launches Authorized Generic of Zomig (zolmitriptan) Tablets and Orally Disintegrating Tablets in the U S "

Impax Laboratories Launches Authorized Generic of Zomig (zolmitriptan) Tablets and Orally Disinte ... [Published BioPortfolio - May 17 2013]

...that resources are allocated and aligned with our strategic growth priorities," said Larry Hsu, Ph D , president and CEO, Impax Laboratories Inc. "We will continue to look for opportunities to free up resources that can be invested to best position Impax for a strong future."

Impax Laboratories Q1 net income increases [Published Zecco - May 14 2013]

...landscape and explore all options, including those intended to mitigate the effect of this decision," Endo president and CEO Rajiv De Silva said. "Endo remains committed to patient safety, including appropriate use of our products, as a top priority."

FDA ruling on opioid painkiller deals blow to Endo [Published Drug Store News - May 13 2013]

n "May 10 (Reuters) - The U S FoodFood and Drug Administration on Friday denied Endo Health Solutions' petition to block generic forms of its widely abused prescription pain drug Opana ER, a surprise decision by an agency that has recently come down hard on pain drugs to prevent their abuse."

FDA allows generic forms of Endo Health's Opana ER painkiller [Published Reuters - May 10 2013]

More Content

All (272) | News (114) | Reports (8) | Blogs (58) | Audio/Video (0) | Fact Sheets (0) | Press Releases (92)

sort by: Date \| Relevance
Impax Laboratories, Inc. (IPXL) - Pharmaceutica... [Published TransWorldNews - May 18 2013]
Celsion Shares Moving Higher on Findings from T... [Published BioMedReports - May 18 2013]
3 Healthcare Stocks Stories To Close Out the Tr... [Published Wall St. Cheat Sheet - May 17 2013]
3 Healthcare Stocks Stories To Close Out the Tr... [Published Wall St. Cheat Sheet - May 17 2013]
Impax Labs launches generic version of Zomig [Published CNBC - May 17 2013]
Impax Laboratories Launches Authorized Generic ... [Published Yahoo! Finance - May 17 2013]
Impax Laboratories Launches Authorized Generic ... [Published Street Insider - May 17 2013]
Impax Laboratories Launches Authorized Generic ... [Published BioPortfolio - May 17 2013]
Impax Laboratories Launches Authorized Generic ... [Published Business Wire Health News - May 17 2013]
Form 4 IMPAX LABORATORIES INC For: May 15 Filed... [Published Street Insider - May 16 2013]
Form 4 IMPAX LABORATORIES INC For: May 15 Filed... [Published Street Insider - May 16 2013]
Form 4 IMPAX LABORATORIES INC For: May 15 Filed... [Published Street Insider - May 16 2013]
Form 4 IMPAX LABORATORIES INC For: May 15 Filed... [Published Street Insider - May 16 2013]
Form 4 IMPAX LABORATORIES INC For: May 15 Filed... [Published Street Insider - May 16 2013]
Form 4 IMPAX LABORATORIES INC For: May 15 Filed... [Published Street Insider - May 16 2013]
Form 4 IMPAX LABORATORIES INC For: May 15 Filed... [Published Street Insider - May 16 2013]
Impax Laboratories (IPXL) Showing Bullish Techn... [Published MarketIntelligenceCenter.com - May 16 2013]
Impax Laboratories Q1 net income increases [Published Zecco - May 14 2013]
Form 4 IMPAX LABORATORIES INC For: May 13 Filed... [Published Street Insider - May 14 2013]
Form 4 IMPAX LABORATORIES INC For: May 11 Filed... [Published Street Insider - May 14 2013]
Form 4 IMPAX LABORATORIES INC For: May 11 Filed... [Published Street Insider - May 13 2013]
FDA ruling on opioid painkiller deals blow to Endo [Published Drug Store News - May 13 2013]
What Companies Will This FDA Decision Impact? [Published Wall St. Cheat Sheet - May 13 2013]
What Companies Will This FDA Decision Impact? [Published Wall St. Cheat Sheet - May 13 2013]
Shares of Nektar Therapeutics... [Published Financial News Network online - May 13 2013]
FDA allows generic forms of Endo Health's Opana... [Published Reuters - May 10 2013]
Endo Loses Bid to Thwart Generic Versions of Op... [Published Washington Post - May 10 2013]
Endo Loses Bid to Stop Sales of Generic Painkil... [Published Bloomberg - May 10 2013]
IMPAX Laboratories, Inc. to Present at the Bank... [Published BioSpace - May 10 2013]
IMPAX Laboratories, Inc. (IPXL) to Present at t... [Published BioSpace - May 10 2013]

Blogs

sort by: Date \| Relevance
3 Healthcare Stocks Stories To Close Out the Tr... [Published Wall St. Cheat Sheet - May 17 2013] Impax Laboratories ( NASDAQ:IPXL ): Closing price $18.42On Friday, Impax said that its generics division, Global Pharmaceuticals, began shipment of authorized generic Zomig (zolmitriptan) tablets and orally disintegrating tablets, 2.5 mg and 5 mg, in ...
3 Healthcare Stocks Stories To Close Out the Tr... [Published Wall St. Cheat Sheet - May 17 2013] Impax Laboratories ( NASDAQ:IPXL ): Closing price $18.42 On Friday, Impax said that its generics division, Global Pharmaceuticals, began shipment of authorized generic Zomig (zolmitriptan) tablets and orally disintegrating tablets, 2.5 mg and 5 mg, ...
Impax Laboratories (IPXL) Showing Bullish Techn... [Published MarketIntelligenceCenter.com - May 16 2013] Impax Laboratories Inc. (NASDAQ: IPXL) closed Wednesday's trading session at $17.99. In the past year, the stock has hit a 52-week low of $14.41 and 52-week high of $27.25. Impax Laboratories (IPXL) stock has been showing support around $17.78 and resistance ...
What Companies Will This FDA Decision Impact? [Published Wall St. Cheat Sheet - May 13 2013] The U.S. Food and Drug Administration ruled Friday that a new version of Opana ER, a painkilling drug, does not deter drug abuse better than earlier versions. Companies will be allowed to make generic versions of the older Opana ER, reports The Wall ...
What Companies Will This FDA Decision Impact? [Published Wall St. Cheat Sheet - May 13 2013] The U.S. Food and Drug Administration ruled Friday that a new version of Opana ER, a painkilling drug, does not deter drug abuse better than earlier versions. Companies will be allowed to make generic versions of the older Opana ER, reports The ...

Press Releases

sort by: Date \| Relevance
Impax Laboratories Launches Authorized Generic ... [Published Business Wire Health News - May 17 2013]
Impax Laboratories to Present at the Bank of Am... [Published Business Wire - May 10 2013]
Impax Laboratories to Present at the Bank of Am... [Published Business Wire Science: Science News - May 10 2013]
Impax Laboratories to Present at the Bank of Am... [Published Business Wire Health News - May 10 2013]
IMPAX LABORATORIES 96 HOUR ALERT: Approximately... [Published Business Wire Professional Services News - May 03 2013]

About
Silobreaker
Press Room

Products
Online Service
On-Premises Software

Contact Us
Sales
Support

Legal
Terms of Use
Privacy Policy

Freebase CC-BY

Some image thumbnails are sourced from Freebase, licensed under CC-BY
Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.